These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1579 related articles for article (PubMed ID: 32043983)

  • 1. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
    Russell CD; Millar JE; Baillie JK
    Lancet; 2020 Feb; 395(10223):473-475. PubMed ID: 32043983
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
    Zhao JP; Hu Y; Du RH; Chen ZS; Jin Y; Zhou M; Zhang J; Qu JM; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):183-184. PubMed ID: 32164084
    [No Abstract]   [Full Text] [Related]  

  • 3. What can we learn about corticosteroid therapy as a treatment for COVID-19?
    Tang J
    Osteoporos Int; 2020 Aug; 31(8):1595. PubMed ID: 32519174
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone in the management of covid -19.
    Johnson RM; Vinetz JM
    BMJ; 2020 Jul; 370():m2648. PubMed ID: 32620554
    [No Abstract]   [Full Text] [Related]  

  • 5. On the use of corticosteroids for 2019-nCoV pneumonia.
    Shang L; Zhao J; Hu Y; Du R; Cao B
    Lancet; 2020 Feb; 395(10225):683-684. PubMed ID: 32122468
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia　- Something to Be Concerned About?
    Regazzoni V; Loffi M; Garini A; Danzi GB
    Circ J; 2020 Sep; 84(10):1887. PubMed ID: 32779609
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases.
    Iwabuchi K; Yoshie K; Kurakami Y; Takahashi K; Kato Y; Morishima T
    J Infect Chemother; 2020 Jun; 26(6):625-632. PubMed ID: 32362440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucocorticoid for coronavirus disease 2019: a dilemma].
    Du X; Yu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Mar; 32(3):278. PubMed ID: 32385989
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.
    Stringer KA; Puskarich MA; Kenes MT; Dickson RP
    Pharmacotherapy; 2020 May; 40(5):382-386. PubMed ID: 32267979
    [No Abstract]   [Full Text] [Related]  

  • 10. Research Progress of Drug Treatment in Novel Coronavirus Pneumonia.
    Yan J; Liu A; Huang J; Wu J; Fan H
    AAPS PharmSciTech; 2020 May; 21(4):130. PubMed ID: 32405780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine in the treatment of COVID-19: How to use it waiting for conclusive scientific evidence.
    Cairoli E; Espinosa G
    Med Clin (Barc); 2020 Aug; 155(3):134-135. PubMed ID: 32425245
    [No Abstract]   [Full Text] [Related]  

  • 12. Audio Interview: Tocilizumab and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(17):e114. PubMed ID: 33085870
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
    Taccone FS; Gorham J; Vincent JL
    Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
    [No Abstract]   [Full Text] [Related]  

  • 14. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
    Richardson P; Griffin I; Tucker C; Smith D; Oechsle O; Phelan A; Rawling M; Savory E; Stebbing J
    Lancet; 2020 Feb; 395(10223):e30-e31. PubMed ID: 32032529
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial.
    Qin YY; Zhou YH; Lu YQ; Sun F; Yang S; Harypursat V; Chen YK
    Chin Med J (Engl); 2020 May; 133(9):1080-1086. PubMed ID: 32149773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
    Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
    Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
    [No Abstract]   [Full Text] [Related]  

  • 17. Orthopaedic Considerations Following COVID-19: Lessons from the 2003 SARS Outbreak.
    Patel MS; Gutman MJ; Abboud JA
    JBJS Rev; 2020 Jul; 8(7):e2000052. PubMed ID: 32759612
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 and vitamin D-Is there a link and an opportunity for intervention?
    Jakovac H
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E589. PubMed ID: 32297519
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thinking on clinical rational use of TCM injection in the treatment of novel coronavirus pneumonia (COVID-19)].
    Wang ZF; Wang YP; Zhang HM; Fan YP; Lü C; Wang YY
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(14):1044-1047. PubMed ID: 32294864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of CT findings in a 2019 novel coronavirus (2019-nCoV) pneumonia patient.
    Fang X; Zhao M; Li S; Yang L; Wu B
    QJM; 2020 Apr; 113(4):271-272. PubMed ID: 32073631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 79.